These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 16621245)
1. Differential effects of bisphosphonates on breast cancer cell lines. Verdijk R; Franke HR; Wolbers F; Vermes I Cancer Lett; 2007 Feb; 246(1-2):308-12. PubMed ID: 16621245 [TBL] [Abstract][Full Text] [Related]
2. The cell cycle arrest and the anti-invasive effects of nitrogen-containing bisphosphonates are not mediated by DBF4 in breast cancer cells. Mansouri M; Mirzaei SA; Lage H; Mousavi SS; Elahian F Biochimie; 2014 Apr; 99():71-6. PubMed ID: 24287290 [TBL] [Abstract][Full Text] [Related]
3. Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells. Ebert R; Meissner-Weigl J; Zeck S; Määttä J; Auriola S; Coimbra de Sousa S; Mentrup B; Graser S; Rachner TD; Hofbauer LC; Jakob F Mol Cancer; 2014 Dec; 13():265. PubMed ID: 25496233 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates induce apoptosis in human breast cancer cell lines. Senaratne SG; Pirianov G; Mansi JL; Arnett TR; Colston KW Br J Cancer; 2000 Apr; 82(8):1459-68. PubMed ID: 10780527 [TBL] [Abstract][Full Text] [Related]
5. In vitro toxicity of bisphosphonates on human neuroblastoma cell lines. Vorotnjak M; Boos J; Lanvers-Kaminsky C Anticancer Drugs; 2004 Sep; 15(8):795-802. PubMed ID: 15494642 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971 [TBL] [Abstract][Full Text] [Related]
7. Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro. Dalle Carbonare L; Valenti MT; Bertoldo F; Fracalossi A; Balducci E; Azzarello G; Vinante O; Lo Cascio V Aging Clin Exp Res; 2007 Apr; 19(2):91-6. PubMed ID: 17446718 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells. Dalle Carbonare L; Valenti MT; Azzarello G; Balducci E; Crepaldi G; Realdi G; Vinante O; Giannini S Mol Cell Endocrinol; 2005 Aug; 240(1-2):23-31. PubMed ID: 15978718 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates induce breast cancer cell death in vitro. Fromigue O; Lagneaux L; Body JJ J Bone Miner Res; 2000 Nov; 15(11):2211-21. PubMed ID: 11092402 [TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Fournier P; Boissier S; Filleur S; Guglielmi J; Cabon F; Colombel M; Clézardin P Cancer Res; 2002 Nov; 62(22):6538-44. PubMed ID: 12438248 [TBL] [Abstract][Full Text] [Related]
11. Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay. Knight LA; Conroy M; Fernando A; Polak M; Kurbacher CM; Cree IA Anticancer Drugs; 2005 Oct; 16(9):969-76. PubMed ID: 16162973 [TBL] [Abstract][Full Text] [Related]
12. Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts. Nishiguchi T; Akiyoshi T; Anami S; Nakabayashi T; Matsuyama K; Matzno S J Pharm Pharmacol; 2009 Jun; 61(6):781-8. PubMed ID: 19505369 [TBL] [Abstract][Full Text] [Related]
13. Isoprenoid-independent pathway is involved in apoptosis induced by risedronate, a bisphosphonate, in which Bim plays a critical role in breast cancer cell line MCF-7. Suyama K; Noguchi Y; Tanaka T; Yoshida T; Shibata T; Saito Y; Tatsuno I Oncol Rep; 2007 Nov; 18(5):1291-8. PubMed ID: 17914587 [TBL] [Abstract][Full Text] [Related]
14. Oral bisphosphonates: A review of clinical use in patients with bone metastases. Major PP; Lipton A; Berenson J; Hortobagyi G Cancer; 2000 Jan; 88(1):6-14. PubMed ID: 10618600 [TBL] [Abstract][Full Text] [Related]
15. Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection. Bivi N; Romanello M; Harrison R; Clarke I; Hoyle DC; Moro L; Ortolani F; Bonetti A; Quadrifoglio F; Tell G; Delneri D Genome Biol; 2009; 10(9):R93. PubMed ID: 19744312 [TBL] [Abstract][Full Text] [Related]
16. Osteoblast proliferation and maturation by bisphosphonates. Im GI; Qureshi SA; Kenney J; Rubash HE; Shanbhag AS Biomaterials; 2004 Aug; 25(18):4105-15. PubMed ID: 15046901 [TBL] [Abstract][Full Text] [Related]
17. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase. Stresing V; Fournier PG; Bellahcène A; Benzaïd I; Mönkkönen H; Colombel M; Ebetino FH; Castronovo V; Clézardin P Bone; 2011 Feb; 48(2):259-66. PubMed ID: 20920623 [TBL] [Abstract][Full Text] [Related]
18. The osteogenic activity of human mandibular fracture haematoma-derived progenitor cells is affected by bisphosphonate in vitro. Imai Y; Hasegawa T; Takeda D; Akashi M; Komori T Int J Oral Maxillofac Surg; 2015 Mar; 44(3):412-6. PubMed ID: 25468633 [TBL] [Abstract][Full Text] [Related]
19. Alendronate inhibits proliferation and invasion of human epidermoid carcinoma cells in vitro. Muller S; Migianu E; Lecouvey M; Kraemer M; Oudar O Anticancer Res; 2005; 25(4):2655-60. PubMed ID: 16080508 [TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells. Kaiser T; Teufel I; Geiger K; Vater Y; Aicher WK; Klein G; Fehm T Breast Cancer Res Treat; 2013 Jul; 140(1):35-48. PubMed ID: 23807419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]